2023
Exports
$291MWorld Rnk 15 / 168
Flag Rnk 202 / 1216
2023
PRODUCT COMPLEXITY IN Unpackaged Medicaments
0.55Rnk 344 / 1025
2023
Imports
$374MWorld Rnk 11 / 220
Flag Rnk 309 / 1214
2023
ECONOMIC COMPLEXITY of United Kingdom
1.5Rnk 11 / 132

About

Exports In 2023, United Kingdom exported $291M in Unpackaged Medicaments, making it the 15th largest exporter of Unpackaged Medicaments in the world. At the same year, Unpackaged Medicaments was the 202nd most exported product in United Kingdom. The main destination of Unpackaged Medicaments exports from United Kingdom are: Egypt ($42.7M), United States ($41.2M), Algeria ($39.2M), Tunisia ($31.8M), and Ireland ($17.3M).

The fastest growing export markets for Unpackaged Medicaments of United Kingdom between 2022 and 2023 were Egypt ($30.3M), United States ($28.3M), and Germany ($11.2M).

Imports In 2023, United Kingdom imported $374M in Unpackaged Medicaments, becoming the 11th largest importer of Unpackaged Medicaments in the world. At the same year, Unpackaged Medicaments was the 309th most imported product in United Kingdom. United Kingdom imports Unpackaged Medicaments primarily from: United States ($146M), Israel ($115M), Portugal ($16M), Italy ($12.6M), and Ireland ($10.7M).

The fastest growing import markets in Unpackaged Medicaments for United Kingdom between 2022 and 2023 were United States ($134M), Portugal ($12M), and Singapore ($5.09M).

Latest Trends

November 2024

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (November 2023 - November 2024)£-400k(-2.13%)
IMPORT GROWTH (November 2023 - November 2024)£-24.2M(-64.8%)
MAIN EXPORTER (November 2024)Dover Eurotunnel£11.3M
MAIN DESTINATION (November 2024)Belgium£5.02M

This section shows Unpackaged Medicaments's exports and imports data at subnational level for United Kingdom. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Unpackaged Medicaments over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$291M
IMPORTS (2023)$374M
NET TRADE (2023)-$83M

In 2023, United Kingdom exported $291M in Unpackaged Medicaments. The main destinations of United Kingdom exports on Unpackaged Medicaments were Egypt ($42.7M), United States ($41.2M), Algeria ($39.2M), Tunisia ($31.8M), and Ireland ($17.3M).

In 2023, United Kingdom imported $374M in Unpackaged Medicaments, mainly from United States ($146M), Israel ($115M), Portugal ($16M), Italy ($12.6M), and Ireland ($10.7M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Unpackaged Medicaments EXPORT MARKETS FOR United Kingdom WERE (2022 - 2023):
Egypt$30.3M (245%)
United States$28.3M (220%)
Germany$11.2M (1.06k%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Unpackaged Medicaments BY United Kingdom WERE (2022 - 2023):
Canada-$8.57M (-42.3%)
Netherlands-$2.77M (-54.5%)
Singapore-$2.53M (-66.9%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, United Kingdom's main exporting competitors in Unpackaged Medicaments were:
In 2023, United Kingdom's main importing competitors in Unpackaged Medicaments were:

Explore Visualizations

Trade Value of Unpackaged Medicaments by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $9.3M
TOP IMPORT POTENTIALGermany+ $18.2M

Unpackaged Medicaments’s highest export potential is United States. With an export gap of $9.3M.   Unpackaged Medicaments’s highest import potential is Germany with an import gap of $18.2M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with